Skip to main content
NCBI home page
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 1991 Dec;72(6):725–744.

Evaluation of experimental carcinogenicity studies for human risk assessment.

I F Purchase 1
PMCID: PMC2002452  PMID: 1768616

Full text

PDF
725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Durston W. E., Yamasaki E., Lee F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2281–2285. doi: 10.1073/pnas.70.8.2281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ames B. N., Gold L. S. Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7772–7776. doi: 10.1073/pnas.87.19.7772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson R. L. Early indicators of bladder carcinogenesis produced by non-genotoxic agents. Mutat Res. 1991 Jun;248(2):261–270. doi: 10.1016/0027-5107(91)90061-r. [DOI] [PubMed] [Google Scholar]
  4. Ashby J., Morrod R. S. Detection of human carcinogens. Nature. 1991 Jul 18;352(6332):185–186. doi: 10.1038/352185a0. [DOI] [PubMed] [Google Scholar]
  5. Ashby J., Tennant R. W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat Res. 1991 May;257(3):229–306. doi: 10.1016/0165-1110(91)90003-e. [DOI] [PubMed] [Google Scholar]
  6. Butterworth B. E. Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat Res. 1990 Sep;239(2):117–132. doi: 10.1016/0165-1110(90)90033-8. [DOI] [PubMed] [Google Scholar]
  7. Clayson D. B. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication No. 13. The need for biological risk assessment in reaching decisions about carcinogens. Mutat Res. 1987 May;185(3):243–269. doi: 10.1016/0165-1110(87)90019-4. [DOI] [PubMed] [Google Scholar]
  8. Crouch E., Wilson R. Interspecies comparison of carcionogenic potency. J Toxicol Environ Health. 1979 Nov;5(6):1095–1118. doi: 10.1080/15287397909529817. [DOI] [PubMed] [Google Scholar]
  9. Dietrich D. R., Swenberg J. A. Preneoplastic lesions in rodent kidney induced spontaneously or by non-genotoxic agents: predictive nature and comparison to lesions induced by genotoxic carcinogens. Mutat Res. 1991 Jun;248(2):239–260. doi: 10.1016/0027-5107(91)90060-2. [DOI] [PubMed] [Google Scholar]
  10. Does carcinogenic potency correlate with mutagenic potency in the Ames assay? Nature. 1978 Jul 6;274(5666):19–22. doi: 10.1038/274019a0. [DOI] [PubMed] [Google Scholar]
  11. Doll R. Are we winning the fight against cancer? An epidemiological assessment. EACR--Mühlbock memorial lecture. Eur J Cancer. 1990 Apr;26(4):500–508. doi: 10.1016/0277-5379(90)90025-o. [DOI] [PubMed] [Google Scholar]
  12. Fears T. R., Tarone R. E., Chu K. C. False-positive and false-negative rates for carcinogenicity screens. Cancer Res. 1977 Jul;37(7 Pt 1):1941–1945. [PubMed] [Google Scholar]
  13. Haseman J. K., Huff J. E., Rao G. N., Arnold J. E., Boorman G. A., McConnell E. E. Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N X C3H/HeN)F1 (B6C3F1) mice. J Natl Cancer Inst. 1985 Nov;75(5):975–984. doi: 10.1093/jnci/75.5.975. [DOI] [PubMed] [Google Scholar]
  14. Haseman J. K., Huff J. E. Species correlation in long-term carcinogenicity studies. Cancer Lett. 1987 Oct 30;37(2):125–132. doi: 10.1016/0304-3835(87)90154-6. [DOI] [PubMed] [Google Scholar]
  15. Haseman J. K. Statistical issues in the design, analysis and interpretation of animal carcinogenicity studies. Environ Health Perspect. 1984 Dec;58:385–392. doi: 10.1289/ehp.8458385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hill R. N., Erdreich L. S., Paynter O. E., Roberts P. A., Rosenthal S. L., Wilkinson C. F. Thyroid follicular cell carcinogenesis. Fundam Appl Toxicol. 1989 May;12(4):629–697. [PubMed] [Google Scholar]
  17. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990 Oct 18;347(6294):645–650. doi: 10.1038/347645a0. [DOI] [PubMed] [Google Scholar]
  18. Purchase I. F. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/6. An appraisal of predictive tests for carcinogenicity. Mutat Res. 1982 Jul;99(1):53–17. doi: 10.1016/0165-1110(82)90031-8. [DOI] [PubMed] [Google Scholar]
  19. Rieth J. P., Starr T. B. Experimental design constraints on carcinogenic potency estimates. J Toxicol Environ Health. 1989;27(3):287–296. doi: 10.1080/15287398909531300. [DOI] [PubMed] [Google Scholar]
  20. Shelby M. D., Zeiger E. Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests. Mutat Res. 1990 Jun-Aug;234(3-4):257–261. doi: 10.1016/0165-1161(90)90022-g. [DOI] [PubMed] [Google Scholar]
  21. Thomas G. A., Williams E. D. Evidence for and possible mechanisms of non-genotoxic carcinogenesis in the rodent thyroid. Mutat Res. 1991 Jun;248(2):357–370. doi: 10.1016/0027-5107(91)90068-y. [DOI] [PubMed] [Google Scholar]
  22. Weil C. S., Carpenter C. P., Smyth H. F., Jr Urinary bladder response to diethylene glycol. Calculi and tumors following repeated feeding and implants. Arch Environ Health. 1965 Oct;11(4):569–581. doi: 10.1080/00039896.1965.10664259. [DOI] [PubMed] [Google Scholar]
  23. Woutersen R. A., van Garderen-Hoetmer A., Lamers C. B., Scherer E. Early indicators of exocrine pancreas carcinogenesis produced by non-genotoxic agents. Mutat Res. 1991 Jun;248(2):291–302. doi: 10.1016/0027-5107(91)90063-t. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES